Juarez D, Buono R, Matulis S, Gupta V, Duong M, Yudiono J, et al. Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors. Cancer Res Commun. 2023;3:2497-2509 pubmed publisher

Herron R, Kunisky A, Madden J, Anyaeche V, Maung M, Hwang H. A twin UGUA motif directs the balance between gene isoforms through CFIm and the mTORC1 signaling pathway. elife. 2023;12: pubmed publisher

Prislusky M, Lam J, Contreras V, Ng M, Chamberlain M, Fields M, et al. The Septin Cytoskeleton is Required for Plasma Membrane Repair. bioRxiv. 2023;: pubmed publisher

Gonthier K, Weidmann C, Berthiaume L, Jobin C, Lacouture A, Lafront C, et al. Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer. Mol Oncol. 2023;: pubmed publisher

Panizza E, Regalado B, Wang F, Nakano I, Vacanti N, Cerione R, et al. Proteomic analysis reveals microvesicles containing NAMPT as mediators of radioresistance in glioma. Life Sci Alliance. 2023;6: pubmed publisher

Hu C, Wang A, Fan D, Worth M, Chen Z, Huang J, et al. Cancer-derived mutation in the OGA stalk domain promotes cell malignancy through dysregulating PDLIM7 and p53. Res Sq. 2023;: pubmed publisher

Rajabian N, Ikhapoh I, Shahini S, Choudhury D, Thiyagarajan R, Shahini A, et al. Methionine adenosyltransferase2A inhibition restores metabolism to improve regenerative capacity and strength of aged skeletal muscle. Nat Commun. 2023;14:886 pubmed publisher

Blankenship C, Xie J, Benz C, Wang A, Ivarsson Y, Jiang J. A novel binding site on the cryptic intervening domain is a motif-dependent regulator of O-GlcNAc transferase. Res Sq. 2023;: pubmed publisher

Prifti D, Lauzier A, Elowe S. A commercial ARHGEF17/TEM4 antibody cross-reacts with Nuclear Mitotic Apparatus protein 1 (NuMA). PLoS ONE. 2022;17:e0268848 pubmed publisher

Kamada H, Yasuhira S, Shibazaki M, Amano H, Maesawa C. DUSP4 Inactivation Leads to Reduced Extracellular Signal‒Regulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells. J Invest Dermatol. 2022;: pubmed publisher

La T, Chen S, Guo T, Zhao X, Teng L, Li D, et al. Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells. Theranostics. 2021;11:9605-9622 pubmed publisher

Norton J, Augert A, Eastwood E, Basom R, Rudin C, MacPherson D. Protein neddylation as a therapeutic target in pulmonary and extrapulmonary small cell carcinomas. Genes Dev. 2021;35:870-887 pubmed publisher

Ghosh M, Saha S, Bettke J, Nagar R, Parrales A, Iwakuma T, et al. Mutant p53 suppresses innate immune signaling to promote tumorigenesis. Cancer Cell. 2021;: pubmed publisher

Nollet E, Cardo Vila M, Ganguly S, Tran J, Schulz V, Cress A, et al. Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer. Oncogene. 2020;: pubmed publisher

Mourikis T, Benedetti L, Foxall E, Temelkovski D, Nulsen J, Perner J, et al. Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma. Nat Commun. 2019;10:3101 pubmed publisher

Frank S, Schulz V, Miranti C. A streamlined method for the design and cloning of shRNAs into an optimized Dox-inducible lentiviral vector. BMC Biotechnol. 2017;17:24 pubmed publisher